Advertisement

COVID-19 Federal Responses: Thursday, October 6, 2022

COVID-19 Federal Responses: Thursday, October 6, 2022

Noteworthy stories related to the pandemic are decreasing so this will be our last FEDERAL UPDATE. We will continue to keep membership advised of all the latest developments. Thank you for your interest and continued support.

White House and Federal Agencies

  • The CDCremovedCOVID-19 travel advisories listed by country. Moving forward, the CDC will announce travel advisories for countries based on the risk of a COVID-19 variant concern.
  • The CDCredefinesan individual as “up to date” with COVID vaccinations when the eligible individual received both primary series vaccines and the most recent booster dose.
  • The CDCreportedCOVID variant BA.4.6 makes up approximately 13% of existing COVID cases while BA.5 made up approximately 81.3%.
  • The Supreme Courtstruck downa lawsuit from 10 states challenging the Biden Administration for mandating vaccinations in healthcare facilities.

Vaccine, Testing, and Treatment

  • Approximately 7.6 million Americans havereceivedthe new bivalent Omicron booster, according to the CDC. This represents 3.6% of eligible Americans.
  • A new Kaiser Family Foundation studyfound:
    • Approximately 33% of all adults have received or intend to receive the new bivalent Omicron booster.
    • Approximately 45% of adults 65 and older have received or intend to receive the new bivalent Omicron booster.
  • A study from the杂志的感染reportedPaxlovid does not pose a significant risk for COVID-19 reinfection compared other COVID-19 treatments.
  • The American Academy of Physical Medicine and Rehabilitationissuedguidelines for the diagnosis and treatment of pediatric patients with Long-COVID.

Advertisement